Browsing by Subject "Targeted therapy"

Now showing 1 - 5 of 5
  • Thumbnail Image
    Publication
    Open Access
    Biomarkers for novel targeted therapies of hepatocellular carcinoma
    (Murcia : F. Hernández, 2009) Okamoto, Kinya; Neureiter, Daniel
    Increasing insights into molecular alterations of signalling pathways have led to the development of specific targeted therapies for cancer. Due to the high specificity of monoclonal antibodies or small molecule inhibitors, identification of patients who will benefit from these therapeutics is crucial for treatment success. Furthermore, as classical endpoints of clinical trials are not fully applicable to targeted therapies, biomarkers for monitoring treatment response have to be identified. The recent introduction of a multi-kinase inhibitor for the treatment of liver cancer has accelerated efforts in the field of biomarker research. As further novel targeted therapies are on the horizon for liver cancer therapy, we will here review candidate markers for new hepatocellular carcinoma therapies, with a focus on EGF- and VEGF-receptor related pathways.
  • Thumbnail Image
    Publication
    Open Access
    Cancer stem cells: A new target for cancer therapy
    (Universidad de Murcia. Departamento de Biología Celular e Histología, 2018) Li, Qianhui; Wu, Jiayu; Chen, Shuo; Zhao, Yang
    The introduction of the theory of cancer stem cells (CSCs) has provided a new direction and perspective for our understanding of the nature and origin of tumors. Cancer stem cells are believed to be responsible for the treatment failure, drug tolerance, metastasis, and recurrence of tumors. However, it remains a challenge to identify or isolate tumor stem cells and determine their regulatory mechanisms. Therefore, further understanding of the biological characteristics and functions of CSCs is of great practical significance and value to develop new methods of tumor diagnosis and treatment, and may bring new hope patients with cancer
  • Thumbnail Image
    Publication
    Open Access
    CD26 dipeptidyl peptidase IV and its role in cancer
    (Murcia : F. Hernández, 2004) Pro, B.; Dang, N.H.
    CD26/Dipeptidyl Peptidase IV (DPPIV) is a 110-kDa glycoprotein that is expressed on numerous cell types and has multiple biological functions. A key facet of CD26/DPPIV biology is its enzymatic activity and its physical and functional interaction with other molecules. The substrates of CD26/DPPIV are proline-containing peptides and include growth factors, chemokines, neuropeptides, and vasoactive peptides. DPPIV plays an important role in immune regulation, signal transduction, and apoptosis. Furthermore, CD26 appears to play an important role in tumor progression. In the present review, we summarize key aspects of CD26/DPPIV involvement in tumor biology and its potential role in cancer development and behavior.
  • Thumbnail Image
    Publication
    Open Access
    CSN6: a promising target for cancer prevention and therapy
    (Universidad de Murcia, Departamento de Biologia Celular e Histiologia, 2020) Hou, Jianbing; Cui, Hongjuan
    CSN6 has recently received increased attention as a multifunctional protein involved in protein stability. CSN6 plays an important role in controlling cellular proliferation, apoptosis and metastasis, modulating signal transduction, as well as regulating DNA damage and repair. Most studies have demonstrated that CSN6 is significantly upregulated in human malignant tumors such as cervical cancer, papillary thyroid cancer, colorectal cancer, breast cancer, lung adenocarcinoma, and glioblastoma, and its expression is usually correlated with poor prognosis. In this review, we summarize recent available findings regarding the oncogenic role of CSN6 in tumors, and provide a better understanding of CSN6 function at the molecular level and its potential therapeutic implications in combating human cancers
  • Thumbnail Image
    Publication
    Open Access
    The role of RhoC in malignant tumor invasion, metastasis and targeted therapy
    (Universidad de Murcia. Departamento de Biología Celular e Histología, 2018) Guan, Xue; Chen, Shuo; Zhao, Yang
    As an important member of the RhoGTPase family, RhoC has various biological functions, such as regulating cytoskeleton reorganization, influencing cell adhesion, and migration. During recent decades, RhoC has been proven to be involved in the invasion and metastasis of malignant tumor and is thus a promising target of tumor therapy. This review focuses on the molecular mechanism of RhoC in invasion and metastasis of malignant tumors, as well as its research prospects as a potential target for tumor therapy.